Log In
Print this Print this

TARGTepo (MDGN-201) (formerly Epodure)

  Manage Alerts
Collapse Summary General Information
Company Medgenics Inc.
DescriptionTransdermal biopump implant device that produces erythropoietin (EPO)
Molecular Target Erythropoietin (EPO)
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPhase I/II
Standard IndicationAnemia
Indication DetailsTreat anemia in chronic kidney disease (CKD) patients; Treat anemia in dialysis patients; Treat anemia in end-stage renal disease (ESRD) and chronic kidney disease (CKD) patients; Treat anemia in patients with end-stage renal disease (ESRD)
Regulatory Designation


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today